<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04766151</url>
  </required_header>
  <id_info>
    <org_study_id>27</org_study_id>
    <nct_id>NCT04766151</nct_id>
  </id_info>
  <brief_title>Nitrate Use to Obtain Radial Spasm Embarrassment (NURSE - TTS Trial)</brief_title>
  <acronym>NURSE-TTS</acronym>
  <official_title>A Randomised, Double-blind, Parallel Group, Efficacy and Safety Study of Transdermal Patch Nitroglycerin in the Prevention of Coronary Artery Spasm, During Coronary Angiography/ Angioplasty (NURSE-TTS - Nitrate Use to Obtain Radial Spasm Embarrassment)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>424 General Military Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Aristotle University Of Thessaloniki</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>424 General Military Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Transradial cardiac catheterization and percutaneous coronary intervention are increasingly&#xD;
      being performed worldwide in elective and emergency procedures, with many centres adopting&#xD;
      the transradial route as their first choice of arterial access. One of the most common&#xD;
      complications encountered during transradial procedures is radial artery spasm. The aim of&#xD;
      this study is to evaluate the Efficacy and Safety of the use of transdermal Glyceryl&#xD;
      trinitrate patches applied to skin before cardiac catheterization to prevent the occurrence&#xD;
      of radial artery spasm during transradial access cardiac catheterization.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2021</start_date>
  <completion_date type="Anticipated">June 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Radial Spasm occurrence</measure>
    <time_frame>Immediately after the end of the procedure</time_frame>
    <description>Radial spasm is measured by the exerting force (in Newton) removing the sheath from the patient</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Successful radial puncture</measure>
    <time_frame>During radial puncture and catheterization</time_frame>
    <description>The success is defined by the fast radial puncture and catheterization and is measured by the time of radial catheterization</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>VRS-4 pain scale</measure>
    <time_frame>During the whole procedure</time_frame>
    <description>The pain during the procedure is measured by the four-category verbal rating scale (VRS-4)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>State-Trait Anxiety Inventory (STAI)</measure>
    <time_frame>During the whole procedure</time_frame>
    <description>The anxiety during the procedure is measured by the State - Trait Anxiety Inventory (STAI)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Radial Artery Spasm</condition>
  <arm_group>
    <arm_group_label>Transdermal glyceryl trinitrate patches</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Transdermal placebo patches</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Transdermal glyceryl trinitrate 10mg patches</intervention_name>
    <description>Transdermal patches applied to skin 30 minutes before cardiac catheterization</description>
    <arm_group_label>Transdermal glyceryl trinitrate patches</arm_group_label>
    <other_name>Nitrong tts 10mg- Lavipharm S.A.</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo patches</intervention_name>
    <description>Transdermal placebo patches applied to skin 30 minutes before cardiac catheterization</description>
    <arm_group_label>Transdermal placebo patches</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male or female 18 -85 years old who has been admitted for scheduled coronary&#xD;
             angiography by radial artery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Prior same radial artery catheterization&#xD;
&#xD;
          -  Positive Allen test&#xD;
&#xD;
          -  Severe Hypotension (SBP&lt;100 mmHg)&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Ongoing Acute Myocardial Infarction&#xD;
&#xD;
          -  Ongoing cardiogenic shock&#xD;
&#xD;
          -  Known History of Nitrates intolerance/allergy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Fotios Oikonomou, MD, PhD</last_name>
    <phone>00306977618318</phone>
    <email>economouf@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ioannis Doundoulakis, MD</last_name>
    <phone>00306946002830</phone>
    <email>doudougiannis@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>424 GeneralMH</name>
      <address>
        <city>Thessaloniki</city>
        <zip>56429</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fotios Oikonomou, MD, PhD</last_name>
      <phone>+306977618318</phone>
      <email>economouf@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Fotios Oikonomou, MD, Phd</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ioannis Doundoulakis, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Myrto Samara, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Iliada Kalamakidou, RN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Georgios Papazisis, MD, Phd</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 15, 2021</study_first_submitted>
  <study_first_submitted_qc>February 20, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 23, 2021</study_first_posted>
  <last_update_submitted>February 20, 2021</last_update_submitted>
  <last_update_submitted_qc>February 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>424 General Military Hospital</investigator_affiliation>
    <investigator_full_name>Fotios Oikonomou</investigator_full_name>
    <investigator_title>Consultant Interventional Cardiologist - Head of Cath Lab</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muscle Cramp</mesh_term>
    <mesh_term>Spasm</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nitroglycerin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

